Literature DB >> 29924324

Suspected Exposure to Filoviruses Among People Contacting Wildlife in Southwestern Uganda.

Tierra Smiley Evans1, Leonard Tutaryebwa2, Kirsten V Gilardi1, Peter A Barry3, Andrea Marzi4, Meghan Eberhardt3, Benard Ssebide5, Michael R Cranfield5, Obed Mugisha2, Emmanuel Mugisha2, Scott Kellermann6, Jonna A K Mazet1, Christine K Johnson1.   

Abstract

Background: Human and filovirus host interactions remain poorly understood in areas where Ebola hemorrhagic fever outbreaks are likely to occur. In the Bwindi region of Uganda, a hot spot of mammalian biodiversity in Africa, human livelihoods are intimately connected with wildlife, creating potential for exposure to filoviruses.
Methods: We tested samples from 331 febrile patients presenting to healthcare facilities near Bwindi Impenetrable Forest, Uganda, by polymerase chain reaction (PCR) analysis and Western blot, using recombinant glycoprotein antigens for Ebola virus (EBOV), Sudan virus (SUDV), Bundibugyo virus (BDBV), and Marburg virus. Behavioral data on contact with wildlife were collected to examine risk factors for filovirus seropositivity.
Results: All patients were negative for active filovirus infection, by PCR analysis. However, patients were seroreactive to SUDV (4.7%), EBOV (5.3%), and BDBV (8.9%), indicating previous exposure. Touching duikers was the most significant risk factor associated with EBOV seropositivity, while hunting primates and touching and/or eating cane rats were significant risk factors for SUDV seropositivity. Conclusions: People in southwestern Uganda have suspected previous exposure to filoviruses, particularly those with a history of wildlife contact. Circulation of filoviruses in wild animals and subsequent spillover into humans could be more common than previously reported.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29924324      PMCID: PMC6927880          DOI: 10.1093/infdis/jiy251

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  40 in total

1.  An outbreak of Ebola in Uganda.

Authors:  S I Okware; F G Omaswa; S Zaramba; A Opio; J J Lutwama; J Kamugisha; E B Rwaguma; P Kagwa; M Lamunu
Journal:  Trop Med Int Health       Date:  2002-12       Impact factor: 2.622

2.  Morbidity and mortality of wild animals in relation to outbreaks of Ebola haemorrhagic fever in Gabon, 1994-2003.

Authors:  Sally A Lahm; Maryvonne Kombila; Robert Swanepoel; Richard F W Barnes
Journal:  Trans R Soc Trop Med Hyg       Date:  2006-09-28       Impact factor: 2.184

3.  Rapid molecular strategy for filovirus detection and characterization.

Authors:  Junhui Zhai; Gustavo Palacios; Jonathan S Towner; Omar Jabado; Vishal Kapoor; Marietjie Venter; Allen Grolla; Thomas Briese; Janusz Paweska; Robert Swanepoel; Heinz Feldmann; Stuart T Nichol; W Ian Lipkin
Journal:  J Clin Microbiol       Date:  2006-11-01       Impact factor: 5.948

4.  Single immunization with a monovalent vesicular stomatitis virus-based vaccine protects nonhuman primates against heterologous challenge with Bundibugyo ebolavirus.

Authors:  Darryl Falzarano; Friederike Feldmann; Allen Grolla; Anders Leung; Hideki Ebihara; James E Strong; Andrea Marzi; Ayato Takada; Shane Jones; Jason Gren; Joan Geisbert; Steven M Jones; Thomas W Geisbert; Heinz Feldmann
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

5.  Enzyme-linked immunosorbent assay for detection of filovirus species-specific antibodies.

Authors:  Eri Nakayama; Ayaka Yokoyama; Hiroko Miyamoto; Manabu Igarashi; Noriko Kishida; Keita Matsuno; Andrea Marzi; Heinz Feldmann; Kimihito Ito; Masayuki Saijo; Ayato Takada
Journal:  Clin Vaccine Immunol       Date:  2010-09-22

6.  Ebola hemorrhagic fever outbreaks in Gabon, 1994-1997: epidemiologic and health control issues.

Authors:  A J Georges; E M Leroy; A A Renaut; C T Benissan; R J Nabias; M T Ngoc; P I Obiang; J P Lepage; E J Bertherat; D D Bénoni; E J Wickings; J P Amblard; J M Lansoud-Soukate; J M Milleliri; S Baize; M C Georges-Courbot
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

7.  Multiple Ebola virus transmission events and rapid decline of central African wildlife.

Authors:  Eric M Leroy; Pierre Rouquet; Pierre Formenty; Sandrine Souquière; Annelisa Kilbourne; Jean-Marc Froment; Magdalena Bermejo; Sheilag Smit; William Karesh; Robert Swanepoel; Sherif R Zaki; Pierre E Rollin
Journal:  Science       Date:  2004-01-16       Impact factor: 47.728

8.  Response to imported case of Marburg hemorrhagic fever, the Netherland.

Authors:  Aura Timen; Marion P G Koopmans; Ann C T M Vossen; Gerard J J van Doornum; Stephan Günther; Franchette van den Berkmortel; Kees M Verduin; Sabine Dittrich; Petra Emmerich; Albert D M E Osterhaus; Jaap T van Dissel; Roel A Coutinho
Journal:  Emerg Infect Dis       Date:  2009-08       Impact factor: 6.883

9.  Ebola virus antibody prevalence in dogs and human risk.

Authors:  Loïs Allela; Olivier Boury; Régis Pouillot; André Délicat; Philippe Yaba; Brice Kumulungui; Pierre Rouquet; Jean-Paul Gonzalez; Eric M Leroy
Journal:  Emerg Infect Dis       Date:  2005-03       Impact factor: 6.883

10.  Wild animal mortality monitoring and human Ebola outbreaks, Gabon and Republic of Congo, 2001-2003.

Authors:  Pierre Rouquet; Jean-Marc Froment; Magdalena Bermejo; Annelisa Kilbourn; William Karesh; Patricia Reed; Brice Kumulungui; Philippe Yaba; André Délicat; Pierre E Rollin; Eric M Leroy
Journal:  Emerg Infect Dis       Date:  2005-02       Impact factor: 6.883

View more
  6 in total

1.  Spillover of ebolaviruses into people in eastern Democratic Republic of Congo prior to the 2018 Ebola virus disease outbreak.

Authors:  Tracey Goldstein; Manjunatha N Belaganahalli; Eddy K Syaluha; Jean-Paul K Lukusa; Denise J Greig; Simon J Anthony; Alexandre Tremeau-Bravard; Riddhi Thakkar; Adrian Caciula; Nischay Mishra; W Ian Lipkin; Jasjeet K Dhanota; Brett R Smith; Victoria M Ontiveros; Nistara Randhawa; Michael Cranfield; Christine K Johnson; Kirsten V Gilardi; Jonna A K Mazet
Journal:  One Health Outlook       Date:  2020-11-04

2.  Associations Between Antibody Fc-Mediated Effector Functions and Long-Term Sequelae in Ebola Virus Survivors.

Authors:  Dominic Paquin-Proulx; Bronwyn M Gunn; Aljawharah Alrubayyi; Danielle V Clark; Matthew Creegan; Dohoon Kim; Hannah Kibuuka; Monica Millard; Salim Wakabi; Leigh Anne Eller; Nelson L Michael; Randal J Schoepp; Matthew J Hepburn; Lisa E Hensley; Merlin L Robb; Galit Alter; Michael A Eller
Journal:  Front Immunol       Date:  2021-05-20       Impact factor: 7.561

3.  Filovirus-reactive antibodies in humans and bats in Northeast India imply zoonotic spillover.

Authors:  Pilot Dovih; Eric D Laing; Yihui Chen; Dolyce H W Low; B R Ansil; Xinglou Yang; Zhengli Shi; Christopher C Broder; Gavin J D Smith; Martin Linster; Uma Ramakrishnan; Ian H Mendenhall
Journal:  PLoS Negl Trop Dis       Date:  2019-10-31

4.  Global shifts in mammalian population trends reveal key predictors of virus spillover risk.

Authors:  Christine K Johnson; Peta L Hitchens; Pranav S Pandit; Julie Rushmore; Tierra Smiley Evans; Cristin C W Young; Megan M Doyle
Journal:  Proc Biol Sci       Date:  2020-04-08       Impact factor: 5.530

Review 5.  A new threat from an old enemy: Re‑emergence of coronavirus (Review).

Authors:  Anca Oana Docea; Aristidis Tsatsakis; Dana Albulescu; Oana Cristea; Ovidiu Zlatian; Marco Vinceti; Sterghios A Moschos; Dimitris Tsoukalas; Marina Goumenou; Nikolaos Drakoulis; Josef M Dumanov; Victor A Tutelyan; Gennadii G Onischenko; Michael Aschner; Demetrios A Spandidos; Daniela Calina
Journal:  Int J Mol Med       Date:  2020-03-27       Impact factor: 4.101

6.  Development of a multiplex microsphere immunoassay for the detection of antibodies against highly pathogenic viruses in human and animal serum samples.

Authors:  Rebecca Surtees; Daniel Stern; Katharina Ahrens; Nicole Kromarek; Angelika Lander; Petra Kreher; Sabrina Weiss; Roger Hewson; Emma K Punch; John N Barr; Peter T Witkowski; Emmanuel Couacy-Hymann; Andrea Marzi; Brigitte G Dorner; Andreas Kurth
Journal:  PLoS Negl Trop Dis       Date:  2020-10-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.